Research Topics
| Guillermo Ruiz-IrastorzaSummaryAffiliation: Hospital de Cruces Country: Spain Publications
| Collaborators
|
Detail Information
Publications
[The antiphospholipid syndrome in the 21st century]Guillermo Ruiz-Irastorza
Hospital de Cruces, Barakaldo, Bizkaia, Espana
Med Clin (Barc) 133:390-6. 2009..Low dose aspirin should be given to every pregnant woman with antiphospholipid antibodies, with the addition of low molecular weight heparin in those with previous thrombosis, previous fetal death or failure of monotherapy with aspirin...
Changes in vitamin D levels in patients with systemic lupus erythematosus: Effects on fatigue, disease activity, and damageGuillermo Ruiz-Irastorza
Hospital de Cruces, Barakaldo, Spain
Arthritis Care Res (Hoboken) 62:1160-5. 2010..To analyze whether changes in serum 25-hydroxyvitamin D (25[OH]D) levels affect activity, irreversible organ damage, and fatigue in systemic lupus erythematosus (SLE)...
High impact of antiphospholipid syndrome on irreversible organ damage and survival of patients with systemic lupus erythematosusGuillermo Ruiz-Irastorza
Servicio de Medicina Interna, Hospital de Cruces, Universidad del Pais Vasco Euskal Herriko Unibertsitatea, Bizkaia, Spain
Arch Intern Med 164:77-82. 2004..Whether antiphospholipid syndrome (APS) is the cause of increased irreversible organ damage and mortality in lupus patients is not well established...
Antiphospholipid syndromeGuillermo Ruiz-Irastorza
Service of Internal Medicine, Hospital de Cruces University of the Basque Country, Bizkaia, Spain
Lancet 376:1498-509. 2010..Hydroxychloroquine is a potential additional treatment for this syndrome. Possible future therapies for non-pregnant patients with antiphospholipid syndrome are statins, rituximab, and new anticoagulant drugs...
Predictors of major infections in systemic lupus erythematosusGuillermo Ruiz-Irastorza
Department of Internal Medicine, Hospital de Cruces, University of the Basque Country, Pza Cruces s n, Barakaldo, Bizkaia, Spain
Arthritis Res Ther 11:R109. 2009..Infections commonly complicate the course of systemic lupus erythematosus (SLE). Our aim is to investigate the clinical predictors of major infections in patients with SLE...
Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic reviewG Ruiz-Irastorza
Servicio de Medicina Interna, Hospital de Cruces, University of the Basque Country, 48903 Bizkaia, Spain
Ann Rheum Dis 69:20-8. 2010..The aim of the present work was to analyse all the published evidence of the beneficial and adverse effects of AM therapy in systemic lupus erythematosus (SLE)...
Vitamin D deficiency in systemic lupus erythematosus: prevalence, predictors and clinical consequencesG Ruiz-Irastorza
Servicio de Medicina Interna, Hospital de Cruces, 48903 Bizkaia, Spain
Rheumatology (Oxford) 47:920-3. 2008..We aimed to establish the prevalence, predictors and clinical consequences of vitamin D deficiency in patients with SLE...
A systematic review of secondary thromboprophylaxis in patients with antiphospholipid antibodiesGuillermo Ruiz-Irastorza
Hospital de Cruces, and University of the Basque Country, Bizkaia, Spain
Arthritis Rheum 57:1487-95. 2007..To systematically review the efficacy and safety data of different therapeutic approaches in patients with antiphospholipid antibodies (aPL) and thrombosis...
Stroke and antiphospholipid syndrome: the treatment debateG Ruiz-Irastorza
Servicio de Medicina Interna, Hospital de Cruces, 48903 Bizkaia, Spain
Rheumatology (Oxford) 44:971-4. 2005..Due to the often devastating consequences of stroke, we believe there is a place for prolonged, high-intensity anticoagulation in patients with APS and cerebral arterial thrombosis...
Antiphospholipid antibodies predict early damage in patients with systemic lupus erythematosusG Ruiz-Irastorza
Service and Department of Internal Medicine, Hospital de Cruces, Universidad del Pais Vasco Euskal Herriko Unibertsitatea, Bizkaia, The Basque Country, Spain
Lupus 13:900-5. 2004..11-10.03) and increasing damage since diagnosis (OR 2.46, 95% CI 1.24-4.87). No autoantibody was a predictor of the outcome 'SDI > or = 1 or death at five years'. The conclusion was that aPL predict early damage in patients with SLE...
Antimalarials may influence the risk of malignancy in systemic lupus erythematosusG Ruiz-Irastorza
Servicio de Medicina Interna, Hospital de Cruces, 48903 Bizkaia, Spain
Ann Rheum Dis 66:815-7. 2007..Recent studies suggest that antimalarials have antineoplastic properties...
Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosusG Ruiz-Irastorza
Department of Internal Medicine, Hospital de Cruces, University of the Basque Country, Bizkaia, Spain
Lupus 15:577-83. 2006..14 (95% CI 0.04-0.48). Our study shows a protective effect of antimalarials against thrombosis and an increased survival of SLE patients taking these drugs. These data support the routine use of antimalarials in all patients with SLE...
Transiently positive anticardiolipin antibodies and risk of thrombosis in patients with systemic lupus erythematosusAgustin Martinez-Berriotxoa
Service of Internal Medicine, Hospital de Cruces, Universidad del Pais Vasco Euskal Herriko Unibertsitatea, Bizkaia, The Basque Country, Spain
Lupus 16:810-6. 2007..Risk of thrombosis is not increased in SLE patients with negative LA and transiently positive aCL, even fulfilling Sapporo laboratory criteria, when compared with aPL-negative SLE patients...
Lupus and pregnancy: integrating clues from the bench and bedsideGuillermo Ruiz-Irastorza
Department of Internal Medicine, Hospital de Cruces, University of the Basque Country, Bizkaia, Spain
Eur J Clin Invest 41:672-8. 2011..Postpartum follow-up is important...
Antiphospholipid syndrome in pregnancyGuillermo Ruiz Irastorza
Department of Internal Medicine, Hospital de Cruces, University of the Basque Country, 48903 Bizkaia, Spain
Rheum Dis Clin North Am 33:287-97, vi. 2007..Doppler studies of the umbilical and uterine arteries play an important role in predicting APS-related complications during pregnancy...
Intensity and duration of anticoagulation therapy in antiphospholipid syndromeIñigo Les
Autoimmune Diseases Research Unit, Service of Internal Medicine, Hospital Universitario Cruces, Bizkaia, Spain
Semin Thromb Hemost 38:339-47. 2012..Nevertheless, anticoagulation regimes of shorter duration could be given in selected patients with venous thromboembolism who have transient risk factors and a low-risk profile...
Managing lupus patients during pregnancyGuillermo Ruiz-Irastorza
Service and Department of Internal Medicine, Hospital de Cruces, University of the Basque Country, Bizkaia, Spain
Best Pract Res Clin Rheumatol 23:575-82. 2009..Post-partum follow-up is also essential...
The treatment of antiphospholipid syndrome: a harmonic contrastGuillermo Ruiz Irastorza
Department of Internal Medicine, Hospital de Cruces, University of the Basque Country, 48903 Barakaldo, Bizkaia, Spain
Best Pract Res Clin Rheumatol 21:1079-92. 2007..Correction of vascular risk factors and a high-risk management of pregnancy, including Doppler studies of the uterine and umbilical vessels, are warranted. Hydroxychloroquine and statins are likely to become important in the future...
Pulmonary hypertension in systemic lupus erythematosus: prevalence, predictors and diagnostic strategyGuillermo Ruiz-Irastorza
Autoimmune Diseases Research Unit, Department of Internal Medicine, Hospital Universitario Cruces, University of the Basque Country, UPV EHU, Bizkaia, Spain
Autoimmun Rev 12:410-5. 2013..To investigate the prevalence and predictors of pulmonary hypertension (PH) in patients with systemic lupus erythematosus (SLE) and to validate a diagnostic strategy...
Glucocorticoid use and abuse in SLEGuillermo Ruiz-Irastorza
Servicio de Medicina Interna Hospital de Cruces, 48903 Bizkaia, Spain
Rheumatology (Oxford) 51:1145-53. 2012..5 mg of prednisone seem to minimize adverse effects. Combination therapy with HCQ and the judicious use of immunosuppressive drugs help to keep prednisone therapy within those limits...
Management of thrombosis in antiphospholipid syndrome and systemic lupus erythematosus in pregnancyGuillermo Ruiz-Irastorza
Service and Department of Internal Medicine, Hospital de Cruces, University of the Basque Country, Bizkaia, Spain
Ann N Y Acad Sci 1051:606-12. 2005..Peripartum thromboprophylaxis with LMWH in women receiving aspirin-only regimens and prevention of osteoporosis in those treated with heparin are considered essential in the medical management of these patients...
Cardiac valve replacement in patients with antiphospholipid syndromeJosé Gabriel Erdozain
Hospital Universitario Cruces, Barakaldo, Spain
Arthritis Care Res (Hoboken) 64:1256-60. 2012..To analyze the results of cardiac valve replacement in a multicenter cohort of patients with antiphospholipid syndrome (APS) and to identify prognostic factors of poor outcome...
Antiphospohlipid syndrome in obstetricsAlvaro Danza
Autoimmune Diseases Research Unit, Department of Internal Medicine, Hospital Universitario Cruces, University of the Basque Country, Bizkaia, Spain
Best Pract Res Clin Obstet Gynaecol 26:65-76. 2012..Close blood pressure control and early detection of proteinuria, together with Doppler studies of the utero-placental circulation should be included in the management protocol...
